ID   QSER1_HUMAN             Reviewed;        1735 AA.
AC   Q2KHR3; Q6ZU30; Q6ZUR5;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   28-JUN-2023, entry version 124.
DE   RecName: Full=Glutamine and serine-rich protein 1;
GN   Name=QSER1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 82-1258 (ISOFORM 1), AND VARIANTS ILE-385 AND
RP   SER-1018.
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1696 (ISOFORM 1), AND VARIANTS
RP   ILE-385 AND SER-1018.
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1239, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-949; SER-1230; SER-1231;
RP   THR-1341 AND SER-1348, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1341, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1211; SER-1230; SER-1231;
RP   THR-1341 AND SER-1348, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-586; SER-615; SER-886 AND
RP   SER-987, VARIANT [LARGE SCALE ANALYSIS] SER-1018, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1058 AND LYS-1083, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [15]
RP   FUNCTION, INTERACTION WITH TET1, AND SUBCELLULAR LOCATION.
RX   PubMed=33833093; DOI=10.1126/science.abd0875;
RA   Dixon G., Pan H., Yang D., Rosen B.P., Jashari T., Verma N., Pulecio J.,
RA   Caspi I., Lee K., Stransky S., Glezer A., Liu C., Rivas M., Kumar R.,
RA   Lan Y., Torregroza I., He C., Sidoli S., Evans T., Elemento O., Huangfu D.;
RT   "QSER1 protects DNA methylation valleys from de novo methylation.";
RL   Science 372:0-0(2021).
CC   -!- FUNCTION: Plays an essential role in the protection and maintenance of
CC       transcriptional and developmental programs. Protects many bivalent
CC       promoters and poised enhancers from hypermethylation, showing a marked
CC       preference for these regulatory elements over other types of promoters
CC       or enhancers. Mechanistically, cooperates with TET1 and binds to DNA in
CC       a common complex to inhibit the binding of DNMT3A/3B and therefore de
CC       novo methylation. {ECO:0000269|PubMed:33833093}.
CC   -!- SUBUNIT: Interacts with TET1. {ECO:0000269|PubMed:33833093}.
CC   -!- SUBCELLULAR LOCATION: Chromosome {ECO:0000269|PubMed:33833093}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q2KHR3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2KHR3-2; Sequence=VSP_039815, VSP_039816;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI12936.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAC86397.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK125391; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK126023; BAC86397.1; ALT_SEQ; mRNA.
DR   EMBL; AC107939; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC112935; AAI12936.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_001070254.1; NM_001076786.2.
DR   AlphaFoldDB; Q2KHR3; -.
DR   SMR; Q2KHR3; -.
DR   BioGRID; 122924; 94.
DR   IntAct; Q2KHR3; 48.
DR   MINT; Q2KHR3; -.
DR   STRING; 9606.ENSP00000382241; -.
DR   GlyConnect; 2855; 1 O-GlcNAc glycan (2 sites).
DR   GlyCosmos; Q2KHR3; 10 sites, 1 glycan.
DR   GlyGen; Q2KHR3; 33 sites, 2 O-linked glycans (33 sites).
DR   iPTMnet; Q2KHR3; -.
DR   PhosphoSitePlus; Q2KHR3; -.
DR   BioMuta; QSER1; -.
DR   DMDM; 308153569; -.
DR   EPD; Q2KHR3; -.
DR   jPOST; Q2KHR3; -.
DR   MassIVE; Q2KHR3; -.
DR   MaxQB; Q2KHR3; -.
DR   PaxDb; Q2KHR3; -.
DR   PeptideAtlas; Q2KHR3; -.
DR   ProteomicsDB; 61307; -. [Q2KHR3-1]
DR   ProteomicsDB; 61308; -. [Q2KHR3-2]
DR   Antibodypedia; 1555; 88 antibodies from 20 providers.
DR   DNASU; 79832; -.
DR   GeneID; 79832; -.
DR   KEGG; hsa:79832; -.
DR   UCSC; uc001mty.4; human. [Q2KHR3-1]
DR   AGR; HGNC:26154; -.
DR   CTD; 79832; -.
DR   DisGeNET; 79832; -.
DR   GeneCards; QSER1; -.
DR   HGNC; HGNC:26154; QSER1.
DR   HPA; ENSG00000060749; Low tissue specificity.
DR   MIM; 619440; gene.
DR   neXtProt; NX_Q2KHR3; -.
DR   PharmGKB; PA143485589; -.
DR   VEuPathDB; HostDB:ENSG00000060749; -.
DR   eggNOG; KOG4805; Eukaryota.
DR   HOGENOM; CLU_000708_2_0_1; -.
DR   InParanoid; Q2KHR3; -.
DR   OrthoDB; 3109299at2759; -.
DR   PhylomeDB; Q2KHR3; -.
DR   TreeFam; TF333141; -.
DR   PathwayCommons; Q2KHR3; -.
DR   SignaLink; Q2KHR3; -.
DR   BioGRID-ORCS; 79832; 10 hits in 1158 CRISPR screens.
DR   ChiTaRS; QSER1; human.
DR   GenomeRNAi; 79832; -.
DR   Pharos; Q2KHR3; Tdark.
DR   PRO; PR:Q2KHR3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q2KHR3; protein.
DR   Bgee; ENSG00000060749; Expressed in caput epididymis and 190 other tissues.
DR   ExpressionAtlas; Q2KHR3; baseline and differential.
DR   Genevisible; Q2KHR3; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   InterPro; IPR025451; DUF4211.
DR   PANTHER; PTHR14709:SF2; GLUTAMINE AND SERINE-RICH PROTEIN 1; 1.
DR   PANTHER; PTHR14709; UNCHARACTERIZED; 1.
DR   Pfam; PF13926; DUF4211; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosome; Isopeptide bond;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..1735
FT                   /note="Glutamine and serine-rich protein 1"
FT                   /id="PRO_0000288933"
FT   REGION          267..301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          414..440
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          479..518
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          533..561
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          964..1033
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1073..1132
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1178..1217
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1256..1286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1441..1532
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        964..982
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        994..1030
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1073..1091
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1199..1216
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1266..1286
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1446..1483
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1488..1509
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         586
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         615
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         886
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         949
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         987
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         1230
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         1231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         1239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         1341
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:21406692"
FT   MOD_RES         1348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   CROSSLNK        1058
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        1083
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         243..481
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039815"
FT   VAR_SEQ         1730..1735
FT                   /note="VQQKCS -> TGMLGEMQSVSVSSTRRSEQQNILEAGKSKIKVPVSGDC
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039816"
FT   VARIANT         385
FT                   /note="V -> I (in dbSNP:rs1022586)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_056975"
FT   VARIANT         644
FT                   /note="Q -> R (in dbSNP:rs2297781)"
FT                   /id="VAR_032535"
FT   VARIANT         1018
FT                   /note="N -> S (in dbSNP:rs7940077)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0007744|PubMed:23186163"
FT                   /id="VAR_032536"
FT   VARIANT         1304
FT                   /note="N -> D (in dbSNP:rs16923676)"
FT                   /id="VAR_032537"
FT   CONFLICT        291
FT                   /note="S -> P (in Ref. 1; AK125391)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        486
FT                   /note="D -> N (in Ref. 1; AK125391)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1075
FT                   /note="R -> G (in Ref. 1; AK125391)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1247
FT                   /note="S -> P (in Ref. 1; AK125391)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1258
FT                   /note="D -> E (in Ref. 1; AK125391)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1735 AA;  189972 MW;  9FC28818DBB42A92 CRC64;
     MNFLSTAESR TAQAAASGTT LLPQFRAPSW QTGMHSSAAT ELFATGPLPS TGTLPPSLSA
     YQHPTTFSNR NFATTSPLVL QDSTFNTTSN GILSHHDPLL QIKTSQGTVP TALAFERLGS
     SVLSNSIPPQ SSTYRSAQES APHLLQPQFS LLPSALGGSQ QTPQAYSSTL FTSSTASIER
     ALLRECSVIK HHQRPSGTQS IQAQLTGSQH SLHSYLSNSS VVNFQETTRQ SSLSCSPIGD
     STQVSNGGLQ QKTSQVSVEL AQSYSSAIPS SGYPPSTTKI KSCSTEQPLT STKTPKPQSI
     IPPVQTLSYS KPLHNQSSVI SGQAQIYSTA QLPSLLSVSQ SQNYGLVQPH NVPSIVHSQV
     YRSSKVEKLP PLYKTLTFSG SSQTVTPENQ TLNYSSNQQE VLSSVTNENY PAQTRDLSSV
     SQSQSYSSGH SQGLSPVSQT QVSYSSQSQV LSVVSLSESY ASGESLTLTA PSLSYSSASR
     AQNLPDSSPT QNYISMHSSQ NVQTQESSSP QSQKFLPAVQ SSSFASSTHC QTLQNNITSP
     DPKSYAERKL DSDVYPSSKQ EDGFPMQELQ VLQPQASLES STQRLSDGEI NAQESTYKVS
     KADDRYSQSV IRSNSRLEDQ VIGVALQASK KEESVVGSVT QLNQQIGQVN NAATLDLKNS
     TNLIQTPQIR LNTKDLKQQH PLILKVHESK VQEQHDQIIN ASSQIQIPNH ALGHGHQASL
     PNTQVLLDSA CDLQILQQSI LQAGLGQVKA SLQAQRVQSP QQIVHPFLQM EGHVIQSNGD
     HSQQQLHPQN SEVMKMDLSE SSKPLQQHLT TKGHFSETNQ HDSKNQFVSL GSMCFPEAVL
     LSDERNILSN VDDILAATAA ACGVTPTDFS KSTSNETMQA VEDGDSKSHF QQSLDVRHVT
     SDFNSMTATV GKPQNINDTS LNGNQVTVNL SPVPALQSKM TLDQQHIETP GQNIPTKVTS
     AVVGPSHEVQ EQSSGPFKKQ SATNLESEED SEAPVDSTLN NNRNQEFVSS SRSISGENAT
     SESEFTLGGD DSGVSMNPAR SALALLAMAQ SGDAVSVKIE EENQDLMHFN LQKKRAKGKG
     QVKEEDNSNQ KQLKRPAQGK RQNPRGTDIY LPYTPPSSES CHDGYQHQEK MRQKIKEVEE
     KQPEVKTGFI ASFLDFLKSG PKQQFSTLAV RMPNRTRRPG TQMVRTFCPP PLPKPSSTTP
     TPLVSETGGN SPSDKVDNEL KNLEHLSSFS SDEDDPGYSQ DAYKSVSTPL TTLDATSDKK
     KKTEALQVAT TSPTANTTGT ATTSSTTVGA VKQEPLHSTS YAVNILENIS SSESSKPIEL
     DGLPSDQFAK GQDTVAIEGF TDEEDTESGG EGQYRERDEF VVKIEDIETF KEALKTGKEP
     PAIWKVQKAL LQKFVPEIRD GQREFAATNS YLGYFGDAKS KYKRIYVKFI ENANKKEYVR
     VCSKKPRNKP SQTIRTVQAK PSSSSKTSDP LASKTTTTKA PSVKPKVKQP KVKAEPPPKK
     RKKWKEEFSS SQSDSSPEIH TSSSDDEEFE PPAPFVTRFL NTRAMKETFK SYMELLVSIA
     LDPDTMQALE KSNDELLLPH MKKIDGMLND NRKRLLLNLH LDQSFKNALE SFPELTIITR
     DSKAKSGGTA ISKIKMNGKA YNKKTLRTSK TTTKSAQEFA VDPEKIQLYS LYHSLHHYKY
     HVYLICKDEI SSVQKKNEDL GQEEIVQLCM KNVKWVEDLF EKFGELLNHV QQKCS
//
